How we work with hospitals
Advisory support that stays inside device and workflow facts.
Nuvasive teams typically prepare value-analysis packets with IFU revision notes, UDI-DI / UDI-PI identifiers, ISO 14971 risk-file excerpts, and service assumptions such as loaner-set lead time and MTTR escalation contacts. When committees debate reusable trays versus single-use disposables, we document both sterility and total-cost assumptions instead of forcing a one-line recommendation.
Limits: we do not invent hospital names for testimonials, do not claim “FDA approved” for 510(k) devices, and do not promise surgical outcomes. Clinical results depend on patient selection, surgeon judgment, sterile processing capacity, and local credentialing.